No medication or supplement currently available can reliably dissolve calcification that has already formed inside your arteries. The deposits are made of the same mineral found in bone, hydroxyapatite, and your body does not have a convenient off-switch for them once they are in place. That said, the picture is more nuanced than a flat “no.” Catheter-based tools can physically crack or shave away calcium during procedures, certain drugs may slow further buildup or change the character of existing deposits, and a handful of experimental therapies are being tested for their ability to halt or partially reverse the process. Understanding what is actually possible, and what is just wishful marketing, requires sorting through several layers of evidence.
Why Calcification Is Not Just Mineral Buildup
For decades, researchers assumed that calcium simply accumulated in artery walls the way limescale coats a pipe. That view has been replaced. Arterial calcification is now recognized as a cell-driven, actively regulated process in which smooth muscle cells in the vessel wall transform into bone-like cells and begin producing mineral deposits on purpose.
Under conditions like high blood pressure, high phosphate levels, or chronic inflammation, these smooth muscle cells lose their normal contractile function and start behaving like the osteoblasts that build bone tissue.1PubMed. Osteogenic transdifferentiation of vascular smooth muscle cells isolated from spontaneously hypertensive rats and potential menaquinone-4 inhibiting effect The process follows signaling pathways remarkably similar to skeletal bone formation.2PubMed Central. Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT This matters for anyone hoping to “clean out” their arteries because it means the calcification is not a passive crust sitting on the surface. It is woven into the biology of the vessel wall itself, which is part of why dissolving it from the outside is so difficult.
Interestingly, some osteoclast-like cells, the type that normally break down bone, have been found in calcified artery walls. In lab studies, bone-marrow-derived osteoclast-like cells reduced calcified mineral content by as much as half without damaging the underlying elastic tissue.3Cardiovascular Research. Two-faced Janus: the dual role of macrophages in atherosclerotic calcification The body may already have a partial resorption mechanism, but inside living arteries it appears to be far too sluggish to reverse established deposits on its own.
Two Kinds of Calcification, Two Different Problems
Not all arterial calcification is the same. Intimal calcification sits inside atherosclerotic plaques and is closely tied to cholesterol-driven disease. Medial calcification occurs in the muscular layer of the artery wall, independent of plaque, and is especially common in people with diabetes, chronic kidney disease, or advanced age. In medial calcification, fine calcium-phosphate granules first appear near the inner elastic membrane and gradually enlarge until large mineral sheets replace healthy tissue and fragment the artery’s structural fibers.4PubMed Central. Medial Arterial Calcification: JACC State-of-the-Art Review
The distinction matters because treatments that help one type do not necessarily help the other. Statins, for example, target cholesterol-laden plaques in the intima. Sodium thiosulfate has mainly been studied for the medial and vascular calcification seen in dialysis patients. When people ask “how do I remove calcification from my arteries,” the honest first question back is: which kind, and how severe?
Catheter-Based Procedures That Crack or Shave Calcium
When calcified coronary arteries are so stiff that a stent cannot be expanded properly, interventional cardiologists turn to tools designed to modify the calcium during the procedure itself. These do not remove calcification from your body in the way you might imagine scrubbing a pipe. Instead, they fracture or debulk the mineral enough to allow a stent to sit correctly and restore blood flow.
Intravascular lithotripsy, or IVL, is one of the newer options. A balloon catheter delivers acoustic shockwaves that crack calcified plaque from the inside, loosening it so the artery can be expanded. Early data show a high rate of procedural success with a low incidence of complications, and IVL is considered a safer, more controlled alternative to traditional atherectomy.5Journal of Education, Health and Sport. Shockwave therapy for coronary calcification: the evolving role of intravascular lithotripsy in coronary interventions It has even been used to treat cases where heavy calcification caused previously implanted stents to fracture.6PubMed. Double stent fracture and in-stent restenosis due to nodular calcification treated with Shockwave coronary intravascular lithotripsy
Rotational and orbital atherectomy are the older workhorses. A tiny diamond-tipped burr spins at high speed to shave away hard calcium. In a head-to-head trial, rotational atherectomy produced more favorable tissue modification and potentially better stent expansion than orbital atherectomy in heavily calcified lesions.7JACC: Cardiovascular Interventions. Direct Comparison of Rotational vs Orbital Atherectomy for Calcified Lesions Guided by Optical Coherence Tomography These procedures are reserved for people who already need an intervention, not offered as preventive treatments.
For calcified carotid arteries, surgical endarterectomy physically opens the artery and removes the diseased plaque. In cases with heavily calcified plaques, restenosis rates at six months were around 19-20% regardless of whether the procedure was open surgery or stenting, suggesting that heavy calcification makes lasting success harder to achieve.8PubMed. Surgical treatment for carotid stenoses with highly calcified plaques
The Statin Paradox
If you have been taking a statin and your coronary calcium score keeps climbing, you are not alone, and it does not necessarily mean the drug is failing. Longer statin use is associated with higher calcium scores. In one large study, people who had been on statins for more than ten years had roughly four and a half times the odds of elevated coronary calcium compared with non-users, even after adjusting for other risk factors.9PubMed Central. Long-term statin therapy is associated with severe coronary artery calcification
That sounds alarming until you look at what the calcium is doing. Imaging research shows that statins do not increase the total volume of calcified plaque. Instead, they shift the calcium toward a denser, more compact form. Denser calcium was associated with slower overall plaque progression, supporting the idea that packing calcium tightly into a plaque may actually stabilize it and reduce the risk of rupture.10JAMA Cardiology. Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition Think of it less like adding more calcium and more like the body converting a crumbly, unstable plaque into a hard, compact one that is less likely to break apart and cause a heart attack. The rising calcium score is real, but its clinical meaning is different from what you might assume.
Vitamin K and Magnesium
Two nutrients stand out in the research on arterial calcification, though neither has been proven to reverse existing deposits in humans.
Vitamin K is required to activate a protein called matrix Gla-protein, or MGP, which acts as a local inhibitor of calcification in the artery wall.11PubMed Central. Vitamin K–Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity Without enough vitamin K, MGP cannot be fully activated, and the brake on calcification weakens. An adequate vitamin K intake is considered important to keep the rate of calcification as low as possible.12Thrombosis and Haemostasis. Matrix Gla-protein: The calcification inhibitor in need of vitamin K Vitamin K2, found in fermented foods, egg yolks, and certain cheeses, is the form most studied for vascular effects. Clinical trials testing whether K2 supplementation can slow coronary calcification in humans are ongoing, but definitive results have not yet arrived.
Magnesium directly interferes with the formation of hydroxyapatite crystals, the mineral that makes up arterial calcium deposits. In lab studies, magnesium reduced the calcium fraction of extracellular crystals by about two-thirds.13PubMed Central. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation It also appears to block the transformation of smooth muscle cells into bone-like cells, hitting the process at a second point.14PubMed Central. Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights Animal models of kidney disease confirm that magnesium supplementation can prevent vascular calcification in rodents.15Nephrology Dialysis Transplantation. Magnesium to prevent kidney disease–associated vascular calcification: crystal clear? The gap between these promising lab and animal findings and proof that taking magnesium supplements reverses calcification in human arteries remains large, however. Prevention and reversal are different hurdles.
Vitamin D occupies an awkward middle ground. Both too little and too much appear to be a problem. Disrupted vitamin D metabolism is linked to imbalances in calcium and phosphate levels that can drive calcification of soft tissue.16PubMed Central. Vitamin D in Vascular Calcification: A Double-Edged Sword? Taking megadoses of vitamin D without medical guidance could theoretically worsen calcification rather than help it.
Sodium Thiosulfate and Dialysis Patients
Sodium thiosulfate is an intravenous drug already approved for other uses (cyanide poisoning, certain skin conditions) that has attracted interest for its ability to chelate calcium and increase its excretion in urine. In a rat model of kidney failure, thiosulfate-treated animals showed no histological evidence of aortic calcification, while roughly three-quarters of untreated animals did.17PubMed. Sodium thiosulfate prevents vascular calcifications in uremic rats
A meta-analysis of studies in dialysis patients found that three to six months of intravenous sodium thiosulfate was associated with meaningfully reduced coronary artery calcium scores compared with standard care.18PubMed Central. Influence of sodium thiosulfate on coronary artery calcification of patients on dialysis: a meta-analysis However, a broader network meta-analysis comparing several treatments found that cinacalcet, a drug that lowers parathyroid hormone levels, ranked highest for reducing vascular calcification in dialysis patients, while sodium thiosulfate did not reach statistical significance against conventional therapy in that particular comparison.19PubMed Central. Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis The evidence is strongest in kidney-disease populations, and sodium thiosulfate is not something you can buy over the counter or self-administer.
EDTA Chelation Therapy
Chelation therapy with EDTA, a compound that binds calcium and heavy metals, has been promoted by alternative medicine practitioners for decades as a way to “clean out” arteries. The scientific record is mixed, and the overall evidence base remains weak.
A Cochrane review of five trials totaling nearly 2,000 participants found that the certainty of the evidence was generally low to very low, limiting the ability to draw strong conclusions about EDTA chelation for atherosclerotic cardiovascular disease.20PubMed Central. Chelation therapy for atherosclerotic cardiovascular disease The largest of those trials, called TACT, did find a signal in one subgroup: among participants with diabetes who had already suffered a heart attack, EDTA infusions reduced a composite cardiovascular endpoint by about half compared with placebo, with roughly a 30% absolute risk reduction.21PubMed Central. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT) That is a striking number, but it came from a subgroup analysis, not the main trial result, which means it needs to be replicated before it can change practice.
A key concern with systemic EDTA is that it does not discriminate. It strips calcium from everywhere, including your blood and bones, which can cause side effects like drops in blood calcium and kidney stress. Researchers have explored a workaround: loading EDTA into nanoparticles coated with antibodies that home in on damaged elastic tissue. In rats, these targeted nanoparticles reversed local arterial calcification after just four injections over two weeks without the systemic side effects of free EDTA.22PubMed Central. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects That approach is still preclinical, but it illustrates why untargeted chelation remains controversial while the concept of dissolving arterial calcium has not been abandoned entirely.
Experimental Drugs on the Horizon
One of the most closely watched experimental therapies is SNF472, an intravenous formulation of myo-inositol hexaphosphate, which is essentially a pharmaceutical version of phytate, a natural compound found in seeds and grains. Phytate is a potent inhibitor of hydroxyapatite crystal growth. It works by interfering with the deposition of new calcium and phosphorus ions onto growing crystals.23PubMed Central. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels
In lab studies of aortic valve cells, SNF472 completely blocked calcification at higher concentrations and reduced ongoing calcification by up to 100% when added early enough.24European Heart Journal. P4487Inhibition of aortic valve calcification by SNF472 in vitro When given after calcification had been underway for two weeks, the inhibition was smaller, suggesting that earlier intervention works better. SNF472 is currently in phase 3 clinical trials and has shown both efficacy and acceptable safety in earlier-phase studies.25PubMed. SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis If it succeeds, it would be the first drug specifically approved to treat vascular calcification, though its primary target population is dialysis patients for now.
Exercise Does Not Slow Calcium Scores, and That Might Be Fine
If you are hoping that running or cycling will shrink your coronary calcium score, the data are not encouraging on that specific front. A large study tracking men and women over time found that the rate of calcium score progression was essentially unaffected by physical activity level. For every additional 500 metabolic-equivalent-minutes of exercise per week, the difference in yearly calcium progression was 0.0%.26JAMA Cardiology. Physical Activity and Progression of Coronary Artery Calcification in Men and Women
In fact, some research has found that highly active people, particularly endurance athletes, tend to have higher coronary calcium scores than sedentary individuals. Before that scares you away from the gym, the interpretation matters. The calcium found in very active people may represent denser, more stable plaques that are less prone to rupture, similar to the pattern seen with statin use.27PubMed Central. The Paradox of Physical Activity and Coronary Artery Calcification: Implications for Cardiovascular Risk Exercise clearly reduces heart attack and stroke risk through many other pathways. It just does not appear to erase calcium deposits.
How Calcium Scores Are Tracked and What Changes Mean
A coronary artery calcium (CAC) scan uses a quick, low-dose CT to quantify how much calcium is in your coronary arteries, reported as an Agatston score. People who go on to have coronary events tend to show much faster calcium progression than those who do not, with median progression values roughly fourteen times higher in the event group in one long-running study.28PubMed Central. Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events Result of the HNR Study (Heinz Nixdorf Recall)
You might assume that if progression predicts events, then slowing progression should prevent them. That logic is appealing, but no randomized controlled trial has yet demonstrated that any therapy slows coronary calcium progression in a way that clearly translates to fewer heart attacks. A comprehensive review concluded that while rising calcium correlates with worsening atherosclerosis, routine serial scanning to track progression cannot currently be recommended in clinical practice, in part because standards for how to define and measure meaningful progression have not been established.29PubMed. Coronary artery calcium progression: an important clinical measurement? A review of published reports A single baseline scan to assess your risk is widely considered useful. Repeat scans to see whether your treatment is “working” are a murkier proposition.
The Gut Microbiome Connection
An emerging area of research is the relationship between gut bacteria and arterial calcification. Metabolites produced by intestinal microbes, including trimethylamine N-oxide (TMAO), short-chain fatty acids, and certain uremic toxins, appear to influence calcification through what researchers call the gut-vascular axis.30PubMed Central. The Role and Mechanism of Gut Microbiota and Metabolites in Vascular Calcification TMAO, produced when gut bacteria metabolize compounds found in red meat and eggs, has been linked to cardiovascular disease broadly, and recent work suggests it may promote the smooth-muscle-cell-to-bone-cell switch that drives calcification. Gut bacteria also synthesize vitamin K2, circling back to the MGP pathway described earlier.
None of this has yet led to a practical intervention you can act on today beyond the general advice to eat a fiber-rich, plant-heavy diet that favors beneficial gut bacteria. But it does suggest that future therapies might target the microbiome as an indirect route to slowing arterial calcification, a possibility that would have seemed far-fetched even a decade ago.